PMC Articles for MedGen (Select 1679488) - PMC

Select item 80483831.

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli, Kelli M. Wilson, Yang Zhang, Erin Beck, Linda Sciuto, Samantha Nichols, Brian Elenbaas, Janusz Puc, Heike Dahmen, Astrid Zimmermann, Jillian Varonin, Christopher W. Schultz, Sehyun Kim, Hirity Shimellis, Parth Desai, Carleen Klumpp-Thomas, Lu Chen, Jameson Travers, Crystal McKnight, Sam Michael, Zina Itkin, Sunmin Lee, Akira Yuno, Min-Jung Lee, Christophe E. Redon, Jessica D. Kindrick, Cody J. Peer, Jun S. Wei, Mirit I. Aladjem, William Douglas Figg, Seth M. Steinberg, Jane B. Trepel, Frank T. Zenke, Yves Pommier, Javed Khan, Craig J. Thomas

Cancer Cell. Author manuscript; available in PMC 2022 Apr 12.

Published in final edited form as: Cancer Cell. 2021 Apr 12; 39(4): 566–579.e7. doi: 10.1016/j.ccell.2021.02.014

PMCID:: PMC8048383

Article PDF–2.5M

Select item 67922602.

CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29

Zhenbang Yang, Chunling Liu, Hongjiao Wu, Yuning Xie, Hui Gao, Xuemei Zhang

BMC Cancer. 2019; 19: 948. Published online 2019 Oct 15. doi: 10.1186/s12885-019-6194-z

PMCID:: PMC6792260

Article PDF–5.7M

Select item 63979203.

Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA

Shinnosuke Takemoto, Yoichi Nakamura, Hiroshi Gyoutoku, Hiroaki Senju, Daiki Ogawara, Takaya Ikeda, Hiroyuki Yamaguchi, Takeshi Kitazaki, Hirofumi Nakano, Katsumi Nakatomi, Shinya Tomari, Shuntaro Sato, Seiji Nagashima, Minoru Fukuda, Hiroshi Mukae

Thorac Cancer. 2019 Mar; 10(3): 452–458. Published online 2019 Jan 9. doi: 10.1111/1759-7714.12958

PMCID:: PMC6397920

Article PDF–285K

Select item 63202674.

Differential Sensitivity Analysis for Resistant Malignancies (DISARM) identifies common candidate therapies across platinum-resistant cancers

Carl M. Gay, Pan Tong, Robert J. Cardnell, Triparna Sen, Xiao Su, Jun Ma, Rasha O. Bara, Faye M. Johnson, Chris Wakefield, John V. Heymach, Jing Wang, Lauren A. Byers

Clin Cancer Res. Author manuscript; available in PMC 2020 Jan 1.

Published in final edited form as: Clin Cancer Res. 2019 Jan 1; 25(1): 346–357. Published online 2018 Sep 26. doi: 10.1158/1078-0432.CCR-18-1129

PMCID:: PMC6320267

Article PDF–1.8M

Select item 55638545.

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart, Sandra Cristea, Aly Valliani, David S. Shames, Abena B. Redwood, You Hong Fan, Lerong Li, Bonnie S. Glisson, John D. Minna, Julien Sage, Don L. Gibbons, Helen Piwnica-Worms, John V. Heymach, Jing Wang, Lauren Averett Byers

Cancer Res. Author manuscript; available in PMC 2017 Aug 21.

Published in final edited form as: Cancer Res. 2017 Jul 15; 77(14): 3870–3884. Published online 2017 May 10. doi: 10.1158/0008-5472.CAN-16-3409

PMCID:: PMC5563854

Article PDF–2.2M

Select item 43957796.

The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer

Yu Fujita, Shigehiro Yagishita, Keitaro Hagiwara, Yusuke Yoshioka, Nobuyoshi Kosaka, Fumitaka Takeshita, Tomohiro Fujiwara, Koji Tsuta, Hiroshi Nokihara, Tomohide Tamura, Hisao Asamura, Makoto Kawaishi, Kazuyoshi Kuwano, Takahiro Ochiya

Mol Ther. 2015 Apr; 23(4): 717–727. Prepublished online 2015 Jan 19. Published online 2015 Feb 10. doi: 10.1038/mt.2015.10

PMCID:: PMC4395779

Article PDF–3.1M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 6

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity